Surrozen

BiotechnologySeries CSouth San Francisco, USsurrozen.com

Latest round

Series C

Last raised

Jun 2020

Total raised

$133M

Investors

6

About Surrozen

Surrozen, Inc. is a biotechnology company focused on leveraging Wnt biology to develop innovative regenerative therapies for various injuries and diseases., founded in 2016 and headquartered in South San Francisco, US, specializes in harnessing the body’s regenerative capabilities. The firm has pivoted its strategy towards developing its proprietary Wnt biology platform.Surrozen focuses on harnessing the body's regenerative capabilities to address various injuries and diseases. The company's core product offerings revolve around its innovative Wnt biology platform, which aims to stimulate tissue repair and promote regeneration in damaged organs. This platform includes SZN-043, which is currently in clinical development for treating conditions that require regenerative solutions. Surrozen primarily targets healthcare providers and pharmaceutical partners, collaborating with researchers and clinicians who seek advanced therapeutic options.Surrozen's revenue model is primarily driven by partnerships and collaborations with biotech firms and healthcare institutions, leveraging its proprietary Wnt biology platform for the development of regenerative therapies.00 mn to support the clinical development of its lead product SZN-043 and further enhance its Wnt biology platform. The company aims to expand its reach within the North American and European markets, focusing on strengthening collaborations with pharmaceutical partners by 2022. There are also plans to introduce additional regenerative therapies designed to address unmet medical needs, with expected launches aligned with ongoing clinical trials and partnerships.

Who invested in Surrozen

6 investors across 3 rounds

See all investors in Surrozen

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series C

    Jun 19, 2020

    Amount

    $50M

    Investors

    Locked

  2. Series B

    Mar 14, 2019

    Amount

    $50M

    Investors

    Locked

  3. Series A

    Feb 15, 2017

    Amount

    $33M

    Investors

    Locked

Questions about Surrozen

Who invested in Surrozen?

Surrozen has 6 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Surrozen raised?

Surrozen has raised 3 venture rounds. Sign up free to see how much each round raised and the total.

When did Surrozen last raise money?

Surrozen's most recent round on record is a Series C, in Jun 2020.

What does Surrozen do?

Surrozen is a biotechnology company.

Where is Surrozen headquartered?

Surrozen is headquartered in South San Francisco, US.

Which VCs invest in companies like Surrozen?

Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Surrozen's stage. Their profiles are linked below.

Raising like Surrozen? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.